Presentation for rcmp 11 06 08
This presentation is the property of its rightful owner.
Sponsored Links
1 / 30

Presentation for RCMP 11/06/08 PowerPoint PPT Presentation

  • Uploaded on
  • Presentation posted in: General

Presentation for RCMP 11/06/08. Brad Johnson Lucian Tira Evangelos Kalogiropoulos Gani Beket. Company History. Founded in 1989 after Medical Waste Tracking Act First acquisition of outside provider in 1993 Launched IPO in 1996 First International operation in 1998.

Download Presentation

Presentation for RCMP 11/06/08

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript

Presentation for rcmp 11 06 08

Presentation for RCMP 11/06/08

  • Brad Johnson

  • Lucian Tira

  • Evangelos Kalogiropoulos

  • Gani Beket

Company history

Company History

Founded in 1989 after Medical Waste Tracking Act

First acquisition of outside provider in 1993

Launched IPO in 1996

First International operation in 1998

Company overview

Company Overview

Offers collection, transportation, treatment, disposal, and recycling of medical waste

Full service for nearly 400,000 customers

Small customers include doctors’ offices and pharmacies

Large customers include pharmaceutical companies, hospitals and blood banks

Foreign customers nearly 23% of revenues

Products and services

Products and Services

  • Regulated Medical Waste Services

    • Handle possibly infected waste and prevent contamination and infection

    • Provided for both large and small customers

    • Service expanding greatly in International market

Products and services1

Products and Services

  • Steri-Safe OSHA Safety & Compliance Program

    • Training for smaller customers to comply with regulations

    • Manual, website support, consulting and supplies

    • Very high margins

Products and services2

Products and Services

  • Bio Systems Integrated Sharps Safety Solution

    • Provides containers for used needles

    • Collection and destruction of needles to prevent sticks

    • Pick them up along with other medical waste

Products and services3

Products and Services

  • Returns Management Services

    • Removal of expired or unsafe products from customers

    • For manufacturers, hospitals, pharmacies and distributors

    • Handle the notification, processing, tracking and compliance reporting

    • Also handle medical recalls

Macroeconomic factors

Macroeconomic Factors

  • Population is getting older and needing more healthcare

  • New president’s healthcare plan

  • Changing Government regulations

  • Tightening credit markets may affect growth

Transaction history

Transaction History

  • Purchased 200 shares in May 2001 @ $19.47

  • Stock split 2:1 in June 2002

  • Sold 200 shares in March 2006

  • Stock split 2:1 May 2007

  • Currently hold 400 shares at $56.20 (11/5) with an effective cost basis of $9.73

Industry overview

Industry overview

Estimated market size:

Global $10.0 Domestic $3.0-$3.2B

“Frost & Sullivan Industry Study and Management Estimates” (including ancillary services & products)

  • Regulated medical waste = any medical waste that can cause an infectious disease such as needles, syringes, gloves etc

  • Five federal agencies supervise regulated waste under a variety of statues

  • U.S. Environmental Protection Agency (“EPA”)

  • U.S. Department of Transportation (“DOT”)

  • Occupational Safety and Health Administration (“OSHA”)

  • U.S. Drug Enforcement Administration (“DEA”)

  • U.S. Postal Service (“USPS”)

  • Different regulations in each state

Industry overview1

Industry overview

Growth factors

  • Aging of population

  • Pressure to reduce Healthcare costs

  • Environmental and Safety Regulation

    Requirements of the Occupational Safety and Health Administration (“OSHA”)

  • Shift to Off-Site Treatment

  • Control of Drug Diversion

    The U.S. Drug Enforcement Administration (“DEA”) has recently emphasized on proper handling of expired or recalled pharmaceuticals.

Company review

Company review

  • Market share: global 10%, domestic 22%

  • Operate in the U.S., Canada, Mexico, the U.K., Ireland and Argentina

  • No direct domestic competitors

  • Insulated from economic cycles

  • Revenue retention rate 95%

  • No large customer exceeds 2% of revenues

  • Over 95% of revenues under long term contracts with automatic renewal

Risk factors competitive strengths

Risk Factors

Governmental Regulation

Low barriers to entry

Technology and patents

Potential environmental liabilities

Foreign exchange


Broad range of services

Established National Network

Diverse Customer Base and Revenue Stability

Ability to integrate Acquisitions

Strong sales Network and Proprietary Database

Experienced Senior Management Team

Risk Factors & Competitive Strengths

Business model

Business Model

Supply specially designed reusable leak-and puncture-resistant plastic containers to large and small-quantity customers

Collect them at intervals specified mainly by contract

Collection of

regulated waste

Temporarily hold small loads of waste until they could be consolidated into truckloads and transported to a processing facility.



Disposal in a third party landfill. Complete documentation to customers for all regulated waste collected

Processing Facility

Recycling or



First they scanned for unacceptable substances and then proceed to various treatments such as Autoclaving, ETD, chemical, Incineration

Current strategies

Current Strategies

  • Expand Range of Services and Products

  • Regulated waste services to pharmaceutical companies and other large-quantity generators

  • Improve Margins

  • Increase the base of small-quantity customers

  • More efficient service strategies for large-quantity customers

  • Seek Complementary Acquisitions

  • Acquire businesses that expand its national and international networks

    Completed 135 acquisitions from 1993-2007, 100 domestic and 35 international

Srcl vs s p 500

SRCL vs. S&P 500

Revenue breakdown

Revenue breakdown

  • LQGs constitute around 37% of total revenues and account for 2.46%

  • of total number of customers

  • Continued penetration of BioSystems led to increase of revenue per LQG

  • Average gross margin in this segment is 21%

Revenue breakdown1

Revenue breakdown

  • SQGs constitute around 63% of total revenues and account for

  • 97.54% of total number of customers

  • Increased adoption of SteriSafe program (including higher priced “select” and “premium” versions)

  • Average gross margin in this segment is 44.3%

Past sources of growth

Past sources of growth

Acquisitions have been fueling growth for years!

Acquisitions pipeline

Acquisitions pipeline

Acquisition deal structures increasingly favor debt…

Pro forma p l

Pro-forma P&L

Source: 10K’s, team estimates

Dupont analysis

DuPont Analysis



Leverage revised

Leverage – revised

Dcf inputs

DCF inputs

Dcf model

DCF model

Dcf results

DCF results

Market price as at 6-Nov-08 is $58

Current stock price implies growth rate of revenues over 20% in the following 5 years!!!

Sensitivity analysis

Sensitivity analysis

1 yr stock performance

1 yr stock performance

“Flight to quality” since October as investors dump other stocks?



  • SELL 200 shares of Stericycle (SRCL) at the market price of $55.00:

    • Tightcredit markets hinder growth at previous rates

    • “Flight to quality” baked into the current price

    • High profit margins and low barriers to entry may lure in competition

  • Login